scispace - formally typeset
M

Mingwei Chen

Researcher at Johns Hopkins University

Publications -  1108
Citations -  63568

Mingwei Chen is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 108, co-authored 536 publications receiving 51351 citations. Previous affiliations of Mingwei Chen include National Taiwan University & Chiba University.

Papers
More filters
Journal ArticleDOI

Fabrication of porous aluminum ceramics beyond device resolution via stereolithography 3D printing

TL;DR: In this article , a new method for fabricating high-resolution porous ceramics using the stereolithography 3D printing technology was presented, where polyamide 12 (PA12) powder, alumina ceramic particles, and acrylic resin as the sacrificial porogen, aggregate, and mixture, respectively.
Journal ArticleDOI

Merkel cell-like artificial mechanoreceptor with high sensitivity and high resolution over a wide linear range

TL;DR: Yang et al. as discussed by the authors proposed an artificial ion mechanoreceptor with the core-shell structured ionic nanofibrous membrane as the sensitive layer by mimicking the biomechanical receptor, which exhibits a high sensitivity (32.70 kPa −1 ), a linear response (R 2 ≈ 0.999), and an ultra-high resolution of 0.035% at 100 kPa.
Journal ArticleDOI

Microbial pathways in the coupling of iron, sulfur, and phosphorus cycles at the sediment-water interface of a river system: An in situ study involving the DGT technique.

TL;DR: In this paper , the authors deployed diffusive gradients in thin films (DGT) probes in situ at the sediment-water interface (SWI) in Fuyang River, Hebei Province, China.
Journal ArticleDOI

Ferritin Nanocaged Doxorubicin Potentiates Chemo‐Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death

TL;DR: In this article , the combination of immunostimulatory chemotherapeutics represents a promising strategy to enhance the effectiveness of immunotherapy for hepatocellular carcinoma using immune checkpoint inhibitors.